Trending

Filed under: News

 

Intercept Pharma Continues Epic Stock Surge After Thursday Blockbuster

Jan 10 2014, 10:51am CST | by

Intercept Pharma Continues Epic Stock Surge After Thursday Blockbuster
Photo Credit: Forbes
 
 
 

Fresh off Thursday’s amazing 280% stock pop, Intercept Pharmaceuticals defied gravity again on Friday, surging another 50% in morning trading. Intercept is flying high after positive results on a new liver disease drug that could help millions of patients in the US.

Intercept halted a trial for the drug, obeticholic acid, before its conclusion — or even 50% of patients had completed treatment — because the drug was apparently already working so well. Its goal is to treat nonalcoholic steatohepatitis (NASH), which can lead to cirrhosis and liver failure.

Analysts are excited about the the prospects for the new drug. Citigroup’s Jonathan Eckard writes that the news shows “major upside surprise and could make significant upside given it is a multi-billion dollar WW market and there are NO approved drugs. NASH is possibly one of the few remaining large untapped market that we could compare to the LDL or diabetes market and is rapidly growing.”

Janney analyst Jim Molloy says there are approximately 22 million Americans who suffer from NASH. “This is a very rare event, and a significant positive for the prospects for the drug,” he writes in a new note. “Importantly only ~50% of the trial participants had completed the trial… and the trial still hit statistical significance at a p=0.0024 which indicates the half that did finish the trial had an extremely robust response. We anticipate OCA could be a potential blockbuster drug for NASH if ultimately approved.”

As of 11:12am EST, Intercept stock traded at $426.50 per share for a market capitalization of $8 billion. As Forbes reported yesterday, the company is backed by Italian biopharma investment group Genextra, whose chairman is former billionaire Francesco Micheli.

Follow Brian on Facebook and Twitter.

six pharma rebels

Source: Forbes

You Might Also Like

Updates

Shopping Deals

 
 
 

<a href="/latest_stories/all/all/31" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

 

Comments

blog comments powered by Disqus

Latest stories

Upload Unlimited Images To The Eyefi Cloud Service
Upload Unlimited Images To The Eyefi Cloud Service
These days it hardly seems possible to buy a camera that doesn’t have GPS, Wi-Fi or even a ‘Smile Detection’ mode built in… but do you really need all those extras? And what if you have a camera that is perfectly...
 
 
Time Travel with Google Maps
Time Travel with Google Maps
MOUNTAIN VIEW, Calif. (AP) — Trips down memory lane are now available on Google's digital maps. The new twist on time travel is debuting Wednesday as part of the "Street View" feature in Google's maps, a navigational...
 
 
Teri Polo Files for Chapter 11 Bankruptcy
Teri Polo Files for Chapter 11 Bankruptcy
The actress in Meet the Parents, Teri Polo apparently owes some people a lot of money. She has filed for Chapter 11 bankruptcy and will not be doing much shopping from now on.
 
 
Google Gets Pulled into Apple vs. Samsung Patent Case
Google Gets Pulled into Apple vs. Samsung Patent Case
There are a lot of interesting facts, presentations, and historical detail coming out of the Apple vs. Samsung patent case currently under way. It is also slowly reeling in Google’s flavour of Android into the spotlight...
 
 
 

The Hottest Photos of Victoria's Secret Fashion Show 2013

 

Viral Stories the Web